Cambridge Nucleomics Revenue

Biotechnology Research • Cambridge, England, United Kingdom • 1-10 Employees

Cambridge Nucleomics revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	No funding

Key Contact at Cambridge Nucleomics

Hendrik Runge

Chief Executive Officer

Company overview

Headquarters	Cambridge, England, United Kingdom
Website	cambridge-nucleomics.com
Keywords	Sepsis, RNA, Diagnostics, Pathogen Detection
Employees	1-10

Cambridge Nucleomics Email Formats

Cambridge Nucleomics uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@cambridge-nucleomics.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@cambridge-nucleomics.com	100%

About Cambridge Nucleomics

One-hour automated point-of-care sepsis testing. Nucleomics is developing diagnostic tests and life science tools based on a single-molecule RNA-counting platform technology developed in Ulrich Keyser's lab at the University of Cambridge. The test is based on hybridisation and enzyme free.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Senior

C-Suite

Intern

Employees by Department

Cambridge Nucleomics has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Cambridge Nucleomics has never raised funding before.

Frequently asked questions

Cambridge Nucleomics is located in Cambridge, England, GB.

Cambridge Nucleomics generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Cambridge Nucleomics has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Cambridge Nucleomics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Cambridge Nucleomics

Hendrik Runge

Chief Executive Officer

4.8

40,000 users